Scientists test new imaging agent to see inside tumors
NCT ID NCT07258836
Summary
This study is testing a new imaging agent called [18F]LY4214835 to see if it is safe and to measure how much radiation it delivers to different organs. It involves both healthy volunteers and people with cancer who will receive a single injection and be followed for about 35 days. The main goal is to gather information on safety and how the tracer moves through and collects in the body, which could help develop better ways to image cancer in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BAMF Health Inc.
NOT_YET_RECRUITINGGrand Rapids, Michigan, 49503, United States
-
Boston Medical Center
NOT_YET_RECRUITINGBoston, Massachusetts, 02118, United States
-
Ichor Research
NOT_YET_RECRUITINGSyracuse, New York, 13210, United States
-
Invicro
RECRUITINGNew Haven, Connecticut, 06510, United States
-
Massachusetts General Hospital (MGH)
NOT_YET_RECRUITINGCharlestown, Massachusetts, 02129, United States
Conditions
Explore the condition pages connected to this study.